Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Schulze-Bergkamen

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|February 19, 2004
Apoptosis in cancer--implications for therapyHenning Schulze-Bergkamen, Peter H Krammer
World Journal of Gastroenterology|March 4, 2014
Targeting cell death signaling in colorectal cancer: current strategies and future perspectivesBruno Christian Koehler, Dirk Jäger, Henning Schulze-Bergkamen
Medical Oncology (Northwood, London, England)|May 25, 2002
Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markersHenning Schulze-Bergkamen, Ivan Zuna, Andreas Teufel, et al.
World Journal of Gastroenterology|May 19, 2007
Genetics of hepatocellular carcinomaAndreas Teufel, Frank Staib, Stephan Kanzler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell deathIngo Schmitz, Andreas Krueger, Sven Baumann, et al.
Biochemistry|April 7, 2004
Long-chain fatty acid uptake into adipocytes depends on lipid raft functionJürgen Pohl, Axel Ring, Robert Ehehalt, et al.
BMC Cancer|October 4, 2006
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis inductionHenning Schulze-Bergkamen, Binje Fleischer, Marcus Schuchmann, et al.
BMC Cancer|March 12, 2014
Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapyNuh N Rahbari, Christoph Reissfelder, Henning Schulze-Bergkamen, et al.
Hepatology (Baltimore, Md.)|June 18, 2005
Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cellsKerstin Herzer, Tom M Ganten, Henning Schulze-Bergkamen, et al.
Oncotarget|September 24, 2017
Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancyBruno Christian Köhler, Nina Waldburger, Kai Schlamp, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|February 19, 2004
Apoptosis in cancer--implications for therapyHenning Schulze-Bergkamen, Peter H Krammer
World Journal of Gastroenterology|March 4, 2014
Targeting cell death signaling in colorectal cancer: current strategies and future perspectivesBruno Christian Koehler, Dirk Jäger, Henning Schulze-Bergkamen
Medical Oncology (Northwood, London, England)|May 25, 2002
Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markersHenning Schulze-Bergkamen, Ivan Zuna, Andreas Teufel, et al.
World Journal of Gastroenterology|May 19, 2007
Genetics of hepatocellular carcinomaAndreas Teufel, Frank Staib, Stephan Kanzler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell deathIngo Schmitz, Andreas Krueger, Sven Baumann, et al.
Biochemistry|April 7, 2004
Long-chain fatty acid uptake into adipocytes depends on lipid raft functionJürgen Pohl, Axel Ring, Robert Ehehalt, et al.
BMC Cancer|October 4, 2006
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis inductionHenning Schulze-Bergkamen, Binje Fleischer, Marcus Schuchmann, et al.
BMC Cancer|March 12, 2014
Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapyNuh N Rahbari, Christoph Reissfelder, Henning Schulze-Bergkamen, et al.
Hepatology (Baltimore, Md.)|June 18, 2005
Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cellsKerstin Herzer, Tom M Ganten, Henning Schulze-Bergkamen, et al.
Oncotarget|September 24, 2017
Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancyBruno Christian Köhler, Nina Waldburger, Kai Schlamp, et al.
Pageof 6